Rchr
J-GLOBAL ID:200901092897216469   Update date: Jun. 09, 2020

Fujiyoshi Masachika

フジヨシ マサチカ | Fujiyoshi Masachika
Affiliation and department:
Job title: Associate Professor
Research field  (1): Clinical pharmacy
Research keywords  (5): Precision Medicine ,  Personalized medicine ,  Biomarker ,  TDM ,  Clinical Pharmacokinetics
Papers (12):
  • Jun Matsumoto, Su Nwe San, Masachika Fujiyoshi, Ayano Kawauchi, Natsumi Chiba, Ran Tagai, Ryoko Sanbe, Shiho Yanaka, Hiroaki Sakaue, Yoshinori Kato, Hiroyoshi Nakamura, Harumi Yamada, Noritaka Ariyoshi. Effect of CYP3A5*3 genetic variant on the metabolism of direct-acting antivirals in vitro: a different effect on asunaprevir versus daclatasvir and beclabuvir. Journal of human genetics. 2020. 65. 2. 143-153
  • Sadahira T, Wada K, Ikawa K, Morikawa N, Mitsui M, Araki M, Fujiyoshi M, Ishii A, Watanabe M, Watanabe T, Nasu Y. Clinical pharmacokinetics of oral azithromycin in epididymal tissue. Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy. 2019. 25. 10. 832-834
  • San SN, Matsumoto J, Saito Y, Koike M, Sakaue H, Kato Y, Fujiyoshi M, Ariyoshi N, Yamada H. Minor contribution of CYP3A5 to the metabolism of hepatitis C protease inhibitor paritaprevir in vitro. Xenobiotica; the fate of foreign compounds in biological systems. 2019. 49. 8. 935-944
  • Izumi-Nakaseko H, Fujiyoshi M, Hagiwara-Nagasawa M, Goto A, Chiba K, Kambayashi R, Naito AT, Ando K, Kanda Y, Ishii I, Sugiyama A. Dasatinib can Impair Left Ventricular Mechanical Function But May Lack Proarrhythmic Effect: A Proposal of Non-clinical Guidance for Predicting Clinical Cardiovascular Adverse Events of Tyrosine Kinase Inhibitors. Cardiovascular toxicology. 2019
  • J. Matsumoto, H. Nakamura, S. San, H. Sato, M. Takezawa, R. Kishi, Y. Kito, J. Sugano, M. Izuki, N. Yanagisawa, N. Ikeda, Y. Saito, Y. Kato, H. Yamada, M. Fujiyoshi, N. Ariyoshi. A proposed simple screening method to determine relative contributions of CYP3A4 and CYP3A5 to drug metabolism in vitro. Personalized Medicine Universe. 2019. 8. 41-44
more...
Education (4):
  • - 2008 Tohoku University Graduate School, Division of Pharmaceutical Sciences
  • - 2005 Tohoku University Graduate School, Division of Pharmaceutical Sciences
  • - 2003 Tohoku University Faculty of Pharmaceutical Sciences
  • - 2003 Tohoku University Faculty of Pharmaceutical Science
Work history (5):
  • 2017/10 - Okayama University Associate Professor
  • 2014/11 - 2017/09 Chiba University Hospital
  • 2014/11 - 2017/09 Chiba University Associate Professor
  • 2011/04 - 2014/10 International University of Health and Welfare, Mita Hospital
  • 2008/04 - 2011/04 Tohoku University Hospital
Awards (2):
  • 2019/07 - The Academy of Pharmaceutical Science and Technology, Japan APSTJ/Global Education Seminar Presentation Award 2019
  • 2005/03 - The Academy of Pharmaceutical Science and Technology, Japan APSTJ/The Nagai Foundation Graduate Student Award
※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page